Hong Zheng

ORCID: 0000-0002-0199-2940
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Vestibular and auditory disorders
  • Hearing, Cochlea, Tinnitus, Genetics
  • Global Cancer Incidence and Screening
  • Ear Surgery and Otitis Media
  • Breast Cancer Treatment Studies
  • Hearing Loss and Rehabilitation
  • PARP inhibition in cancer therapy
  • Ovarian cancer diagnosis and treatment
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Breast Implant and Reconstruction
  • BRCA gene mutations in cancer
  • AI in cancer detection
  • Spinal Fractures and Fixation Techniques
  • Ion channel regulation and function
  • Economic and Financial Impacts of Cancer
  • Health Systems, Economic Evaluations, Quality of Life
  • Hearing Impairment and Communication
  • Mitochondrial Function and Pathology
  • Potassium and Related Disorders
  • Gastroesophageal reflux and treatments
  • Cancer Mechanisms and Therapy
  • Cognitive Science and Mapping
  • Cognitive Science and Education Research
  • Facial Nerve Paralysis Treatment and Research

Sichuan University
2013-2025

West China Hospital of Sichuan University
2010-2024

Peking University
2024

Peking University Cancer Hospital
2024

The University of Texas MD Anderson Cancer Center
2023

AstraZeneca (Brazil)
2023

University of Toledo
2004

Shannon N. Westin Kathleen N. Moore Hye Sook Chon Jung‐Yun Lee Jessica Thomes Pepin and 95 more Michael J. Sundborg Ayelet Shai Joseph de la Garza Shin Nishio Michael A. Gold Ke Wang Kristi McIntyre Todd D. Tillmanns Stephanie V. Blank Jihong Liu Michael McCollum Fernando Contreras Mejía Tadaaki Nishikawa Kathryn P. Pennington Zoltán Novàk Andréia Cristina de Melo Jalid Sehouli Dagmara Klasa-Mazurkiewicz Christos Papadimitriou Marta Gil-Martín Birutė Brasiūnienė Conor Donnelly Paula Michelle del Rosario Xiaochun Liu Els Van Nieuwenhuysen Sophia Frentzas Ganessan Kichendasse Bo Gao Tarek Meniawy Linda Mileshkin Gary Richardson Felicia Roncolato Jean‐François Baurain Maryam Bourhaba Eveline Cuypere Philip R. Debruyne Hannelore Denys Frédéric Forget Brigitte Honhon E. Joosens Els Van Nieuwenhuysen Vanessa da Costa Miranda Andréia Cristina de Melo Joao Daniel Guedes Charles Andreé Joseph de Pádua Nicolas Lazaretti Carolina Martins Vieira André Mattar Daniela Neves Palmeiro Christina Pimentel Oppermann Kussler Pedro Emanuel Rubini Liedke João Soares Nunes Katsuki Arima Tiscoski Allan Covens Lara De Guerké Prafull Ghatage Lucy Gilbert Susie Lau Amit M. Oza Diane Provencher Omar Touhami Congzhu Li Danbo Wang Ge Lou Zhu Genhai Guiling Li Shi Hong Hong Zheng Hongwu Wen Jihong Liu Jing Wang Ke Wang Kui Jiang Li Li Wang Li Min Hao Qi Zhou Gao Qinglei Sihai Liao Songling Zhang Weidong Zhao Xiaohua Wu Wuliang Wang Rutie Yin Ying Cheng Yu Zhang Zhiqing Liang Fernando Contreras Mejía Ángel Luis Martín de Francisco Hernández Carolina Ortiz Lopez Carlos Javier Pacheco Pedro Luis Ramos Guette Jaime Rendon Pereira Julian Rivera Diaz Tomás Sánchez Villegas

Immunotherapy and chemotherapy combinations have shown activity in endometrial cancer, with greater benefit mismatch repair (MMR)-deficient (dMMR) than MMR-proficient (pMMR) disease. Adding a poly(ADP-ribose) polymerase inhibitor may improve outcomes, especially pMMR

10.1200/jco.23.02132 article EN cc-by-nc-nd Journal of Clinical Oncology 2023-10-21

Risk-based breast cancer screening is a cost-effective intervention for controlling in China, but the successful implementation of such requires an accurate prediction model Chinese women.This study aimed to evaluate and compare performance four machine learning algorithms on predicting among women using 10 risk factors.A dataset consisting 7127 cases matched healthy controls was used training testing. We repeated 5-fold cross-validation calculated AUC, sensitivity, specificity, accuracy as...

10.2196/17364 article EN cc-by JMIR Medical Informatics 2020-04-19

PURPOSE The OlympiA randomized phase III trial compared 1 year of olaparib (OL) or placebo (PL) as adjuvant therapy in patients with germline BRCA1/2, high-risk human epidermal growth factor receptor 2–negative early breast cancer after completing (neo)adjuvant chemotherapy ([N]ACT), surgery, and radiotherapy. patient-reported outcome primary hypothesis was that OL-treated may experience greater fatigue during treatment. METHODS Data were collected before random assignment, at 6, 12, 18, 24...

10.1200/jco.23.01214 article EN Journal of Clinical Oncology 2024-02-01
Christian Marth Richard G. Moore Mariusz Bidziński Sandro Pignata Ali Ayhan and 95 more María Jesús Rubio Mario Beiner Marcia Hall Christof Vulsteke Elena Ioana Braicu Kenzo Sonoda Xiaohua Wu Sophia Frentzas André Mattar Stéphanie Lheureux Xiaojun Chen Kosei Hasegawa Manuel Magallanes-Maciel Chel Hun Choi Mariia Shalkova Diego Kaen Peng‐Hui Wang Regina Berger Chinyere E. Okpara Jodi A. McKenzie Lili Yao Robert Orlowski Vivek Khemka Lucy Gilbert Vicky Makker Diego Kaen G. Gomez Abuin Liliana Zamora Margarita Sonia Alfie Ignacio Casarini Michelle Harrison Sumitra Ananda Catherine Shannon Sophia Frentzas Michael Friedländer Tarek Meniawy Bo Gao Sally Baron‐Hay Connie I. Diakos Christian Marth Stephan Polterauer Edgar Petru Marlies De Bock Christof Vulsteke Jean‐François Baurain Toon Van Gorp Sevilay Altıntaş João Paulo da Silveira Nogueira Lima André Mattar Ruffo Freitas‐Júnior RO de Sant'ana Andréia Cristina de Melo Fábio Franke Graziela Zibetti Dal Molin Fernanda Damian João Daniel Cardoso Guedes Susan Ellard Anna V. Tinker Vanessa Samouëlian Suzanne Fortin Paul Bessette Michael Kolinsky Nidhi Kumar Tyagi Josée-Lyne Ethier Lucy Gilbert Stéphanie Lheureux Helen Mackay Charles Henry Lim Xiaohua Wu Lingya Pan Ruifang An Xiaojun Chen Hong Zheng Yumei Wu Jianqing Zhu Shuzhong Yao Xuemei Jia Yi Huang Weiguo Lv Yu Zhang Qi Zhou Cailing Ma Radoslav Chekerov Paweł Mach Ralf Witteler F Marmé Karen Cadoo Jacob Korach Talia Levy Mario Beiner Amnon Amit Paolo Scollo Emanuele Naglieri Sandro Pignata Claudio Zamagni

PURPOSE Lenvatinib plus pembrolizumab (len + pembro) significantly improved progression-free survival (PFS) and overall (OS) versus chemotherapy in previously treated advanced or recurrent endometrial cancer (aEC) the phase III Study 309/KEYNOTE-775. We report results from III, randomized, open-label European Network of Gynaecological Oncological Trial-en9/LEAP-001 study (ClinicalTrials.gov identifier: NCT03884101 ) that evaluated len pembro first-line aEC. METHODS Patients with stage to IV...

10.1200/jco-24-01326 article EN Journal of Clinical Oncology 2024-11-26

To explore the current research status and trends of potassium-competitive acid blockers (P-CABs) in treatment related diseases (ARDs) using bibliometric analysis. We collected publications to P-CAB acid-related Web Science (WOS) Core Collection from establishment database 30 June 2024. evaluated publication volume citation over years WOS platform, visualized authors, countries, institutions, keywords, citations CiteSpace VOSviewer. This study included a total 455 articles. The number has...

10.3389/fphar.2024.1477633 article EN cc-by Frontiers in Pharmacology 2025-01-07

High-quality cancer tissues are essential for future research, especially molecular research. For the sake of better quality tissues, some storage methods chosen according to lab conditions. But impact different storing conditions on RNA, DNA (especially degree methylation), and protein that have undergone a thawing process, is not clear.We analyzed influence including in RNALater solution, normal saline, Opti-mum Cutting Temperature compound (OCT), snap frozen with no protective reagent (as...

10.1089/bio.2015.0029 article EN Biopreservation and Biobanking 2015-10-01

To investigate the correlation between KCNE gene family and Meniere's disease (MD) in Chinese population.This study analyzed single-nucleotide polymorphism (SNP) of KCNE1 KCNE3 genes MD group control familial (FMD) sporadic (SMD) group.A total 653 C/T SNPs had a statistical difference FMD SMD groups (p=0.0082<0.05); 492 A/C were statistically different (genotype p=0.037<0.05 allele p=0.006<0.05).SNPs mutations were, respectively, groups. was key to disease, whereas more important onset SMD.

10.5152/iao.2019.5076 article EN cc-by-nc The Journal of International Advanced Otology 2019-05-03

Background: Horizontal canal BPPV (HC-BPPV) has a higher recurrence rate than PC-BPPV. Which maneuver is better for its prognosis still uncertain.Objective: To compare the long-term after Gufoni and Barbecue maneuver.Materials methods: We prospectively collected 61 cases of HC-BPPV which were initially diagnosed in our hospital from first episode, had already ruled out other diseases. Roll them into group alternatively. After maneuver, we followed up until December 2016. Mean follow-up time...

10.1080/00016489.2020.1725114 article EN cc-by-nc-nd Acta Oto-Laryngologica 2020-02-12

Abstract Background: The primary results from the OlympiA trial were recently reported (NEJM, 2021) after an interim analysis demonstrated statistically significant invasive disease-free survival (DFS) benefit 1 year of olaparib (OL) vs. placebo (PL) 2.5 yrs median follow-up. Although there fewer deaths with OL than PL, overall (OS) did not reach statistical significance threshold prespecified for analysis. initial publication also on adverse event profile, which was similar to that...

10.1158/1538-7445.sabcs21-gs4-09 article EN Cancer Research 2022-02-15

Creative computation is a new research field of computational intelligence, and Intuition plays an important role in creativity. The relationship between intuition, experience, association stimuli described quantitative way. experience achieved by Hebb's law. On the basis definition mutation association, process intuition modeled Hopfield neural networks, crossover operators. cognitive models for simulating are established. Finally, example rendering fractal graphs given to show efficiency...

10.1109/wcica.2004.1341939 article EN 2004-11-08

Abstract Background Little is known about how health insurance policies, particularly in developing countries, may influence breast cancer prognosis. We aimed to examine the association between individual plans and cancer-specific mortality among patients China.Methods included 7,436 women diagnosed with invasive January 1 st , 2009, December 31 2016, at West China Hospital, Sichuan University. The plan of each patient was classified as either urban or rural schemes also categorized...

10.21203/rs.2.24640/v1 preprint EN cc-by Research Square (Research Square) 2020-02-26

Abstract Background: Both breast-conserving surgery and breast reconstruction are less popular in China, although they can improve patients' quality of life. The main reason comes from the economy. There is currently no economic evaluation different surgical treatment options for early cancer. Our study aims to assess impact long-term cost-effectiveness treatments approaches including mastectomy (MAST), therapy (BCT), with (MAST+RECON). Methods: We applied propensity score matching method...

10.21203/rs.3.rs-18258/v2 preprint EN cc-by Research Square (Research Square) 2020-08-20

The rate of genetic deafness in Chengdu is still underestimated.To investigate patients' molecular etiology with profound hearing loss and facilitate counseling for their families, we screened deafness-related genes the population.A total 1427 unrelated patients containing all age groups administrative area City (Sichuan, China) were enrolled this study, average examination 81.13%. Nine loci four deaf-associated (GJB2, GJB3, SLC26A4, mitochondrial 12SrRNA gene) analyzed. Then examined...

10.1080/00016489.2021.2014564 article EN cc-by-nc-nd Acta Oto-Laryngologica 2021-12-22

To determine the preoperative diagnostic accuracy of MRI and otoneural tests (ONT) for acoustic neuroma (AN) in a cohort unselected patients with pontocerebellar angle tumors. find convenient way to screening out potential asymptomatic AN patient earlier. This study was performed central hospital included consecutive sample unilateral incipient tumor referred ONT before surgery. Different features were collected concluded into variables or variable combinations. Those are analyzed compared...

10.3389/fonc.2021.626485 article EN cc-by Frontiers in Oncology 2021-06-29
Coming Soon ...